of these patients 62.5 % ( 10/16 ) had a complete or partial response on cyclophosphamide + cisplatin ( cp ) 87.5 % ( 14/16 ) on cyclophosphamide + doxorubicin + cisplatin ( cap ) and cyclophosphamide + 4'-epi-doxorubicin + cisplatin ( cep ) .
C0056447
cyclophosphamide
C0008838
cisplatin